Pitchkit
  • Docs
  • Pricing
  • Blog
  • Tools
  • Investors
Sign inGet started
Pitchkit

Structure and stress-test your pitch with workflows built from 6+ years of VC dealflow.

Product

  • Overview
  • Pitch deck feedback
  • Pitch deck generator
  • Templates
  • Pricing

Resources

  • Learn
  • Pitch by stage
  • Slide guides
  • Docs
  • Glossary
  • Free tools

Company

  • About
  • Blog
  • Changelog
  • Contact
  • Privacy policy

Ready to pitch?

Start building your investor-ready pitch today. Free forever, no credit card required.

Start free

© 2026 Pitchkit / edgelord.tech

All systems operational
Pitchkit
Back to investor directory
Venture capital
France

Andera Partners

Investment focus

Sectors

Biotech
Healthtech

Investment stages

Seed
Series A
Series B
Growth

Geographic focus

Europe
United States
Global

Investment thesis

Formerly Edmond de Rothschild Investment Partners. Paris-based life sciences VC backing innovative therapeutics and medical technology companies from early through late stage across Europe and the US.

Typical check size

€15M – €60M

Fund size: €456M (BioDiscovery 6)

Browse similar check sizes →

Portfolio highlights

Amolyt Pharma - rare endocrine disease biotech acquired by AstraZeneca for $1.05B
ReViral - UK RSV antiviral biotech acquired by Pfizer (2022)
Corvidia Therapeutics - cardiovascular disease biotech acquired by Novo Nordisk

Contact

www.anderapartners.com
France

Research with AI

Learn more about Andera Partners using AI:

Ask ChatGPTAsk Perplexity

Pitch guides

Learn what Andera Partners and similar investors look for:

Biotech pitch guideHealthtech pitch guide

More investors in France

360 CapitalAlvenBlackFin Capital PartnersBpifranceView all in France

Related resources

Seed fundraising guideSeed pitch deck guideSeries A fundraising guideSeries A pitch deck guideSeries B fundraising guideGrowth fundraising guide
Fundraising in France

Tips, programs, and cultural notes

More Biotech investors

AbingworthACF InvestorsAhren Innovation CapitalAlmi Invest GreenTechView all Biotech investors